News
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently completed a Phase 2 clinical ...
13h
TipRanks on MSNIncyte’s Retifanlimab Study Update: A Potential Game-Changer in Cancer Treatment
Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation recently updated its clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results